Jump to content

Kathryn Zeiler

From Wikipedia, the free encyclopedia
Kathryn Zeiler
Born (1969-06-03) June 3, 1969 (age 55)
Alma materIndiana University

Golden Gate University California Institute of Technology University of Southern California Gould School of Law

California Institute of Technology
OccupationLaw professor
EmployerBoston University School of Law

Kathryn M. Zeiler (born June 3, 1969) is the Nancy Barton Scholar and Professor of Law at Boston University School of Law. Zeiler's work primarily focuses on health law, torts law, law and economics, medical malpractice, and disclosure law.

Biography

[edit]

Zeiler graduated from: Indiana University with a B.S. in business; Golden Gate University with a M.S. in Taxation; and California Institute of Technology with a M.S. in Social Sciences[when?].[1] Zeiler then received her J.D. from University of Southern California Gould School of Law and her Ph.D. in Economics from California Institute of Technology.,[1] Zeiler served as a professor of law at Georgetown University Law Center.[2][3] During her Fall 2010 sabbatical from Georgetown University Law Center, Zeiler participated in a senior fellowship at the Petrie-Flom Center of Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.[4] She was named the Nancy Barton Scholar and Professor of Law positions at Boston University School of Law in 2015 . Zeiler also previously held several visiting professorships at Harvard Law School, NYU School of Law, and Boston University School of Law.[when?][3]  

Scholarship

[edit]

Behavioral economics

[edit]

Zeiler and Charles R. Plott co-authored two articles in the American Economic Review re-examining the methodology used to establish the endowment effect theory:[5] “The Willingness to Pay-Willingness to Accept Gap, the ‘Endowment Effect,’ Subject Misconceptions, and Experimental Procedures for Eliciting Valuations,” (Cited 1137 times, according to Google Scholar [6]) and “Exchange Asymmetries Incorrectly Interpreted as Evidence of Endowment Effect Theory and Prospect Theory” (Cited 364 times, according to Google Scholar.[6]) .[5][7] While less than 10% of legal articles referencing the endowment effect theory cited to Zeiler and Plott's work in the five years following the 2005 article's publication, Zeiler and Plott's work is credited as being among the most prominent challengers to the endowment effect theory and has heavily influenced behavioralist scholarship.[5][8]

The endowment effect theory has previously been called "one of the most robust findings in the psychology of decision making” and is used by behavioral legal scholars to explain the relationship between ownership and value.[5] Zeiler and Plotts' findings challenged the endowment effect theory by arguing that observed disparities between willingness-to-accept (WTA) and willingness-to-pay (WTP) measures are not reflective of human preferences, but rather such disparities stem from encouraged experimental design practices within the field.[9] By developing an elicitation procedure that controls subject misconceptions, Zeiler and Plott found that the endowment effect theory is not sufficient to explain WTA-WTP gaps that are likely the result of subject misconceptions.[9] Since Plott and Zeiler's 2005 and 2007 experiments, a new wave of research has sought to address whether the endowment effect theory stems from reference-dependent preferences.[5] Their findings have notably paved the way for refined and alternative theories regarding the endowment effect, including the Kőszegi-Rabin theory of expectations-based reference points, which explains the absence of the endowment effect in relation to misconceptions about expectations relating to trading probability.[5]

Given the significance of these findings, Zeiler and Plotts' original conclusions have been met with some dispute.[9] There had been speculations that the WTA-WTP gap may vary according to the commodity type (e.g. low-value consumption goods, high-value consumption goods, non-marketed goods, lotteries with goods as prizes, lotteries with money prizes).[9] Critics of Zeiler and Plotts' work have found that while the lack of a WTA-WTP gap has continued to be observed in low cost commodities (like mugs), the WTA-WTP gap seems to persist in lottery systems, even when elicitation procedures attempt to control subject misconceptions.[9][5] Therefore, these critics have argued in favor of "house money" effects, rather than subject misconceptions.[9][5] However, in their 2011 reply to such criticisms, Zeiler and Plott (1) asserted that lottery data is contaminated by irrational choice and distorted beliefs that promote inconsistent risks and (2) argued that other literature does not support a "house money" conjecture.[5] Since these contributions to the field of behavioral economics, Zeiler has continued to advocate for the adoption of more modern views on decision theories into standard law and economic models.[10]

Medical malpractice

[edit]

Zeiler has explored the differences between malpractice payments and jury verdicts, while also discussing the consequences of using malpractice insurance to satisfy malpractice claims.[11] Her work indicates that malpractice awards rarely exceed primary coverage limits, regardless of the damages awarded by juries. Therefore, even though physicians without excess-layer liability coverage are in principle vulnerable to judgments above the standard liability insurance, this is almost never the case. Policy limits almost always limit the effect of larger jury verdicts where verdicts exceed available insurance coverage. Thus, regardless of their malpractice insurance coverage, doctors rarely make out-of-pocket payments to satisfy malpractice awards. In the rare cases in which large jury verdicts or settlements are paid out above general policy limits, these payments are almost always paid by insurers. These findings call into question policy arguments in support of the implementation of damages caps to lower liability insurance premiums and improve patient care.

Methodology

[edit]

Zeiler has advocated for the increased use of empiricism in health law, specifically through the utilization of data and use of the scientific method.[10] Zeiler and Michelle Mello have examined the use of empirical field studies to study causation and policy interventions.[12] While the strict adoption of the scientific method's "gold standard" of the randomized controlled trial can be difficult in the field of health law, Zeiler and Mello argue that fixed-effects models and difference-in-difference models can be used as tools of causal identification in health law studies.[12]

References

[edit]
  1. ^ a b "Kathryn Zeiler | School of Law". www.bu.edu. Retrieved 2020-03-21.
  2. ^ King, Tim (2018-05-21). "Kathryn Zeiler | O'Neill Institute". O'neill. Retrieved 2020-03-21.
  3. ^ a b "Health Law Workshop: Kathryn Zeiler | Petrie-Flom Center". The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. 27 March 2017. Retrieved 2020-03-21.
  4. ^ "About Kathryn Zeiler | Past Senior Fellows/Associates | Petrie-Flom Center". The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. 23 August 2013. Retrieved 2020-03-22.
  5. ^ a b c d e f g h i Marzilli Ericson, Keith; Fuster, Andreas (August 2014). "The Endowment Effect". Annual Review of Economics. 6: 555–579. doi:10.1146/annurev-economics-080213-041320. S2CID 154441446. SSRN 2477775.
  6. ^ a b [1] Google Scholar Author page, Accessed March 12, 2022
  7. ^ Lambert, Thomas, 1971- author. How to regulate : a guide for policymakers. ISBN 978-1-316-53488-5. OCLC 1027400852. {{cite book}}: |last= has generic name (help)CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)
  8. ^ Joshua, Wright; Ginsburg, Douglas (2012). "Behaviors Law and Economics: Its Origins, Fatal Flaws, and Implications for Liberty". Northwestern University Law Review. 106: 1034–1088.
  9. ^ a b c d e f Isoni, Andrea; Loomes, Graham; Sugden, Robert (April 2011). "The Willingness to Pay-Willingness to Accept Gap, the "Endowment Effect," Subject Misconceptions, and Experimental Procedures for Eliciting Valuations: Comment". American Economic Review. 101 (2): 991–1011. doi:10.1257/aer.101.2.991. S2CID 8750389 – via JSTOR.
  10. ^ a b Luppi, Barbara; Parisi, Francesco (2016-06-01). "Optimal liability for optimistic tortfeasors". European Journal of Law and Economics. 41 (3): 559–574. doi:10.1007/s10657-016-9523-6. ISSN 1572-9990. S2CID 146943760.
  11. ^ Hall, Mark A.; Orentlicher, David; Bobinski, Mary Anne; Bagley, Nicholas; Cohen, I. Glenn (2018-02-26). Health Care Law and Ethics. Wolters Kluwer Law & Business. ISBN 978-1-4548-8180-3.
  12. ^ a b Fischman, Robert; Barbash-Riley, Lydia (2018-04-01). "Empirical Environmental Scholarship". Rochester, NY. SSRN 3039687. {{cite journal}}: Cite journal requires |journal= (help)